Natural ligands for CD33-related Siglecs?

Glycobiology

Volumn 19, Issue 8, 2009, Pages 810-812

  Varki, Ajit ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD24 ANTIGEN; CD33 ANTIGEN; LECTIN; MUCIN; PADGEM PROTEIN; SIALIC ACID; SIALIC ACID BINDING IMMUNOGLOBULIN SUPER FAMILY LECTIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL DEATH; EOSINOPHIL; EXON; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; SIALYLATION; SIGNAL TRANSDUCTION; UPREGULATION;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; LECTINS; LIGANDS; POLYSACCHARIDES; PROTEIN BINDING;

EID: 67650145833     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwp063     Document Type: Article

References (30)

1. Angata T, Hayakawa T, Yamanaka M, Varki A, Nakamura M. 2006. Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates. FASEB J. 20:1964-1973.
2. Bai XF, Liu JQ, Liu X, Guo Y, Cox K, Wen J, Zheng P, Liu Y. 2000. The heat-stable antigen determines pathogenicity of self-reactive T cells in experimental autoimmune encephalomyelitis. J Clin Invest. 105:1227-1232.
3. Barrow AD, Trowsdale J. 2006. You say ITAM and I say ITIM, let's call the whole thing off: The ambiguity of immunoreceptor signalling. Eur J Immunol. 36:1646-1653.
4. Bianchi ME, Manfredi AA. 2009. Immunology. Dangers in and out. Science. 323:1683-1684.
5. Blasius AL, Cella M, Maldonado J, Takai T, Colonna M. 2006. Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12. Blood. 107:2474-2476.
6. Brinkman-Van der Linden ECM, Van OECR, Van DW. 1996. Glycosylation of alpha1-acid glycoprotein in septic shock: Changes in degree of branching and in expression of sialyl Lewisx groups. Glycoconjugate J. 13:27-31.
7. Cao H, Lakner U, de Bono B, Traherne JA, Trowsdale J, Barrow AD. 2008. SIGLEC16 encodes a DAP12-associated receptor expressed inmacrophages that evolved from its inhibitory counterpart SIGLEC11 and has functional and non-functional alleles in humans. Eur J Immunol 38:2303-2315.
8. Carlin AF, Uchiyama S, Chang YC, Lewis AL, Nizet V, Varki A. 2009. Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response. Blood. 113:3333-3336.
9. Chen GY, Tang J, Zheng P, Liu Y. 2009. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science. 323:1722-1725.
10. Crocker PR, Feizi T. 1996. Carbohydrate recognition systems: Functional triads in cell-cell interactions. Curr Opin Struct Biol. 6:679-691.
11. Crocker PR, Paulson JC, Varki A. 2007. Siglecs and their roles in the immune system. Nat Rev Immunol. 7:255-266.
12. Crocker PR, Varki A. 2001. Siglecs, sialic acids and innate immunity. Trends Immunol 22:337-342.
13. Dam TK, Brewer CF. 2008. Effects of clustered epitopes in multivalent ligand-receptor interactions. Biochemistry. 47:8470-8476.
14. Epperson TR, Patel KD, McEver RP, Cummings RD. 2000. Noncovalent association of P-selectin glycoprotein ligand-1 and minimal determinants for binding to P-selectin. J Biol Chem. 275:7839-7853.
15. 2+ in neutrophil granulocytes via sialic acid binding immunoglobulin-like lectins (siglecs). FASEB J. 21:4059-4069.
16. Kay R, Rosten PM, Humphries RK. 1991. CD24, a signal transducer modulating B cell activation responses, is a very short peptide with a glycosyl phosphatidylinositol membrane anchor. J Immunol. 147:1412-1416.
17. Kimura N, Ohmori K, Miyazaki K, Izawa M, Matsuzaki Y, Yasuda Y, Takematsu H, Kozutsumi Y, Moriyama A, Kannagi R. 2007. Human B-lymphocytes express alpha2-6-sialylated 6-sulfo-N acetyllactosamine serving as a preferred ligand for CD22/Siglec-2. J Biol Chem. 282:32200-32207.
18. Koenig A, Norgard-Sumnicht KE, Linhardt R, Varki A. 1998. Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins - Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents. J Clin Invest. 101:877-889.
19. Laszik Z, Jansen PJ, Cummings RD, Tedder TF, McEver RP, Moore KL. 1996. P-Selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells. Blood. 88:3010-3021
20. Moore KL, Varki A, McEver RP. 1991. GMP-140 binds to a glycoprotein receptor on human neutrophils: Evidence for a lectin-like interaction. J Cell Biol. 112:491-499.
21. Nitschke L, Floyd H, Ferguson DJ, Crocker PR. 1999 Identification of CD22 ligands on bone marrow sinusoidal endothelium implicated in CD22-dependent homing of recirculating B cells. J Exp Med. 189:1513-1518.
22. Ohl C, Albach C, Altevogt P, Schmitz B. 2003. N-Glycosylation patterns of HSA/CD24 from different cell lines and brain homogenates: A comparison. Biochimie. 85:565-573.
23. Sammar M, Aigner S, Altevogt P. 1997. Heat-stable antigen (mouse CD24) in the brain: Dual but distinct interaction with P-selectin and L1. Biochim Biophys Acta Protein Struct Mol Enzymol. 1337:287-294.
24. Schnaar RL, Collins BE, Wright LP, Kiso M, Tropak MB, Roder JC, Crocker PR. 1998. Myelin-associated glycoprotein binding to gangliosides - Structural specificity and functional implications. Ann NY Acad Sci 845:92-105.
25. Sgroi D, Nocks A, Stamenkovic I. 1996. A single N-linked glycosylation site is implicated in the regulation of ligand recognition by the I-type lectins CD22 and CD33. J Biol Chem. 271:18803-18809.
26. Sgroi D, Varki A, Braesch-Andersen S, Stamenkovic I. 1993. CD22, a B cell-specific immunoglobulin superfamily member, is a sialic acid-binding lectin. J Biol Chem. 268:7011-7018.
27. Van Den Berg TK, Nath D, Ziltener HJ, Vestweber D, Fukuda M, Van Die I, Crocker PR. 2001. Cutting edge: CD43 functions as a T cell counterreceptor for the macrophage adhesion receptor sialoadhesin (Siglec-1). J Immunol. 166:3637-3640.
28. Varki A, Angata T. 2006. Siglecs - the major subfamily of I-type lectins. Glycobiology. 16:1R-27R.
29. Yamanaka M, Kato Y, Angata T, Narimatsu H. 2009. Deletion polymorphism of SIGLEC14 and its functional implications. Glycobiology doi:10.1093/glycob/cwp052.
30. Zhang M, Angata T, Cho JY, Miller M, Broide DH, Varki A. 2007. Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils. Blood. 109:4280-4287.